Higher circulating visfatin levels are associated with increased risk of atrial fibrillation and major adverse cardiovascular events in patients with acute ST-elevation myocardial infarction

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction

  2016cited by this paper
• Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study).

  2016cited by this paper
• Adipokines in Healthy Skeletal Muscle and Metabolic Disease.

  2016cited by this paper
• The relationship between HbA1c & atrial fibrillation after off-pump coronary artery bypass surgery in diabetic patients

  2016cited by this paper
• Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction

  2015cited by this paper
• Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation.

  2015influential reference
• Adiponectin: an accurate biomarker for patients at risk for atrial fibrillation?

  2015cited by this paper
• Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species.

  2015cited by this paper
• High serum adiponectin concentration and low body mass index are significantly associated with increased all-cause and cardiovascular mortality in an elderly cohort, "adiponectin paradox": the Korean Longitudinal Study on Health and Aging (KLoSHA).

  2015cited by this paper
• Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: an analysis of ACS-NSQIP

  2015cited by this paper
• Plasma visfatin levels are associated with major adverse cardiovascular events in patients with acute ST-elevation myocardial infarction.

  2015influential reference
• sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.

  2015cited by this paper
• Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome.

  2014cited by this paper
• Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).

  2014influential reference
• Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis

  2014cited by this paper
• Visfatin/Nampt: An Adipokine with Cardiovascular Impact

  2013influential reference
• Role of adipokines in cardiovascular disease.

  2013cited by this paper
• Effect of the Mediterranean diet on plasma adipokine concentrations in men with metabolic syndrome.

  2013cited by this paper
• Bilirubin Levels and the Burden of Coronary Atherosclerosis in Patients With STEMI

  2013cited by this paper
• A novel adipocytokine visfatin protects against H2O2‐induced myocardial apoptosis: A missing link between obesity and cardiovascular disease

  2013cited by this paper
• Interpretation of elevated plasma visfatin concentrations in patients with ST-elevation myocardial infarction.

  2012cited by this paper
• Prognostic value of circulating adipokine levels and expressions of adipokines in the myocardium of patients with chronic heart failure.

  2012cited by this paper
• Improved Endothelial Function in Patients with Atrial Fibrillation through Maintenance of Sinus Rhythm by Successful Catheter Ablation

  2011cited by this paper
• Visfatin Stimulates a Cellular Renin-Angiotensin System in Cultured Rat Mesangial Cells

  2011cited by this paper
• Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?

  2009cited by this paper
• Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo.

  2009cited by this paper
• Endothelial dysfunction: the first step toward coronary arteriosclerosis.

  2009cited by this paper
• Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes

  2009cited by this paper
• Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.

  2009cited by this paper
• Factors to Predict Recurrence of Atrial Fibrillation in Patients with Hypertension

  2009cited by this paper
• Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.

  2009cited by this paper
• Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis

  2008cited by this paper
• Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism*

  2008cited by this paper
• Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

  2007cited by this paper
• Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.

  2007cited by this paper
• Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization

  2007influential reference
• Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

  2005cited by this paper
• Insulin resistance in type 2 diabetes -- role of the adipokines.

  2005cited by this paper
• Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes.

  2002cited by this paper

• No citing papers are available for this paper.